ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer

NCT00006106 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Lip and Oral Cavity Cancer
Head and Neck Cancer
Oropharyngeal Cancer

Interventions

DRUG: cisplatin
DRUG: fluorouracil
DRUG: ONYX-015

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]